Disitamab vedotin, an antibody-drug conjugate (ADC), targets HER2-expressing cancer cells. It works by binding to HER2, being ...

The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EDT on Tuesday, April 29, 2025. The purpose ...

Johnson & Johnson follows Eli Lilly in spending billions on U.S. manufacturing after President Donald Trump threatened major ...

Johnson & Johnson has laid out plans to raise U.S. investments by 25% to more than $55 billion over the next four years, as a ...

Amvuttra is now approved in the US to treat both cardiomyopathy and polyneuropathy manifestations of ATTR amyloidosis.

Stellantis and its Chinese partner Leapmotor consider Spain the top candidate to produce the B10 electric crossover for the ...

Santander is to shut almost a quarter of its branch network in June, putting 750 jobs at risk. The Spanish owned high street ...

Executives mingled with North Carolina leaders in the city of Wilson to ceremonially break ground on Johnson & Johnson’s ...

Amid rising risks, I favor high-yield stocks with strong business models. Check out the stock picks that offer stability, ...

Johnson & Johnson plans to spend more than $55 billion to build four plants in the U.S. over the next four years, it said on ...

After Trump threatened 25% tariffs on pharma imports, J&J became the latest pharma company to announce investments in the U.S.